Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes

SIMPLE SUMMARY: Despite the approval of new targeted therapies for pancreatic neuroendocrine tumors (PanNETs) over the past decades, the early identification of resistant tumors remains the major challenge, mainly because clear signs of tumor shrinkage are rarely achieved by imaging assessment. Star...

Descripción completa

Detalles Bibliográficos
Autores principales: Cella, Chiara Alessandra, Spada, Francesca, Berruti, Alfredo, Bertolini, Francesco, Mancuso, Patrizia, Barberis, Massimo, Pisa, Eleonora, Rubino, Manila, Gervaso, Lorenzo, Laffi, Alice, Pellicori, Stefania, Radice, Davide, Zorzino, Laura, Calleri, Angelica, Funicelli, Luigi, Petralia, Giuseppe, Fazio, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497075/
https://www.ncbi.nlm.nih.gov/pubmed/36139632
http://dx.doi.org/10.3390/cancers14184471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497075/
https://www.ncbi.nlm.nih.gov/pubmed/36139632
http://dx.doi.org/10.3390/cancers14184471

Ejemplares similares